Literature DB >> 26881572

A rare case of chemotherapy induced reversible cerebral vasoconstriction syndrome in a patient of acute lymphocytic leukemia.

Shilpa Sankhe, Namita Kamath1, Arpita Sahu.   

Abstract

Neurotoxic reactions of chemotherapy occur frequently and are often dose limiting side effects of chemotherapy. It is important to differentiate these various nonneoplastic effects from metastases, or sometimes even from each other, since the therapeutic approach differs accordingly. To arrive at a definitive and comprehensive diagnosis, the radiologist should integrate imaging findings, clinical signs, and laboratory results together. Here we present a unique case of chemotherapy induced reversible cerebral vasoconstriction syndrome in a 13-year-old patient of acute lymphoblastic leukemia.

Entities:  

Mesh:

Year:  2015        PMID: 26881572     DOI: 10.4103/0973-1482.168993

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Targetable driver mutations in multicentric reticulohistiocytosis.

Authors:  Norihiro Murakami; Tomohisa Sakai; Eisuke Arai; Hideki Muramatsu; Daisuke Ichikawa; Shuji Asai; Yoshie Shimoyama; Naoki Ishiguro; Yoshiyuki Takahashi; Yusuke Okuno; Yoshihiro Nishida
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

2.  Reversible cerebral vasoconstriction syndrome after intrathecal cytarabine.

Authors:  Natalia Trombini Mendes; Luiza Ramos de Freitas; Rônney Pinto Lopes; Lohana Santana Almeida da Silva; Francisco Tomaz Meneses de Oliveira
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.